Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ 156.17MCash and Equivalents
VS
Market
Sector
Industry
History
$ 27.98Close
$ 6.28 - $ 27.98 52-Week Range
Ticker Information
Ticker
NTLACompany Name
INTELLIA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQINTELLIA THERAPEUTICS INC - Cash and Equivalents Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
NTLA - CashnEq Historical data
| Date | Cash and Equivalents |
|---|---|
| 6/30/2025 | $ 156.17M |
| 3/31/2025 | $ 126.88M |
| 12/31/2024 | $ 189.18M |
| 9/30/2024 | $ 120.5M |
| 6/30/2024 | $ 130.85M |
| 3/31/2024 | $ 171.98M |
| 12/31/2023 | $ 226.75M |
| 9/30/2023 | $ 168.03M |
| 6/30/2023 | $ 171.81M |
| 3/31/2023 | $ 294.15M |
Key Performance Insights, Last 5 Years
- INTELLIA THERAPEUTICS INC's latest trailing twelve months (TTM) CashnEq stands at $ 179.75M.
- Over the past 5 years, INTELLIA THERAPEUTICS INC's average CashnEq has been $ 188.57M.
- The median CashnEq for INTELLIA THERAPEUTICS INC during this period was $ 158.1M
- INTELLIA THERAPEUTICS INC reached its highest CashnEq over the past 5 years at $ 523.51M.
- The lowest CashnEq recorded by INTELLIA THERAPEUTICS INC in the same timeframe $ 120.5M
INTELLIA THERAPEUTICS INC's CashnEq vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CashnEq Benchmarks
Similar metrics to CashnEq:
- Cash to Assets Ratio - [Calculation] The Cash to Assets Ratio expresses a company’s cash and cash equivalents [CashnEq] as a percentage of total [Assets].
- Net Cash Flow - Change in Cash & Cash Equivalents - [Cash Flow Statement] Represents the amount of increase (decrease) in cash and cash equivalents. Includes cash from operations [NCFO], investing [NCFI] and financing [NCFF], adjusted for the effect of exchange rate changes on cash [NCFX]
- Non-Current Assets - [Balance Sheet] The non-current (long-term) portion of [Assets] that are not easily converted to cash within a year; reported if the company operates a classified balance sheet that segments current and non-current assets.
- Cash Ratio - [Calculation] The Cash Ratio is a liquidity indicator that describes a company's ability to meet short-term obligations with cash and cash equivalents. Calculated by dividing cash and cash equivalents [CashnEq] by current liabilities [LiabilitiesC].
- Current Assets - [Balance Sheet] The current (short-term) portion of [Assets] that are usually convertible to cash within a year; reported if the company operates a classified balance sheet that segments current and non-current assets.
Definition of Cash and Equivalents
[Balance Sheet] Cash and cash equivalents are the sum of [Assets] that are cash or can be converted to cash in less than one year.NTLA - Cash and Equivalents, Last 5 years
$ 120.5M
Minimum
Sep 30, 2024
$ 523.51M
Maximum
Dec 31, 2022
$ 188.57M
Average
$ 158.1M
Median
CashnEq Benchmark AnalysisMarket
The chart above depicts the distribution of CashnEq for companies in the Total Stock Market. The average CashnEq of the companies is $ 98.9M with a standard deviation of $ 119.33M.
The following table provides additional summary stats:
CashnEq in the Market:
| filtered constituents | 3.62K |
|---|---|
| min | $ 0 |
| max | $ 492.42M |
| average | $ 98.9M |
| median | $ 48.02M |
| std | $ 119.33M |